Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umberto Capitanio

Showing results (121-130 of 446) with videos related to

Pageof 45
Sort By:
European Urology Focus|May 7, 2021
Predicting Complications After Robotic Partial Nephrectomy: Back to SimplicityZine-Eddine Khene, Clément Mazouin, Alessandro Larcher, et al.
European Urology|August 9, 2011
The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core systematic schemeVincenzo Scattoni, Marco Raber, Umberto Capitanio, et al.
European Urology Oncology|May 18, 2019
Is Robot-assisted Surgery Contraindicated in the Case of Partial Nephrectomy for Complex Tumours or Relevant Comorbidities? A Comparative Analysis of Morbidity, Renal Function, and Oncologic OutcomesAlessandro Larcher, Umberto Capitanio, Geert De Naeyer, et al.
European Urology Open Science|January 5, 2023
Local Treatment of Recurrent Renal Cell Carcinoma May Have a Significant Survival Effect Across All Risk-of-recurrence GroupsLorenzo Marconi, Teele Kuusk, Umberto Capitanio, et al.
European Urology|September 2, 2009
Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsyVincenzo Scattoni, Marco Raber, Firas Abdollah, et al.
Current Problems in Cancer|June 9, 2022
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidenceUmberto Capitanio, Giuseppe Fallara, Daniele Raggi, et al.
World Journal of Urology|July 27, 2018
Predictive and prognostic effect of inflammatory lymphadenopathies in renal cell carcinomaFabio Muttin, Angela Pecoraro, Alessandro Larcher, et al.
The Prostate|August 1, 2025
Assessing Predictors of Failure After Bladder Neck Incision in Patients Who Developed Bladder Neck Stenosis Following Transurethral Surgery for Benign Prostatic EnlargementLeonardo Quarta, Marco Bandini, Christian Corsini, et al.
Current Problems in Cancer|June 16, 2021
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors?Giuseppe Fallara, Marco Bandini, Alessandro Larcher, et al.
BJU International|October 1, 2010
How can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implicationsUmberto Capitanio, Federico Pellucchi, Andrea Gallina, et al.
Pageof 45

Showing results (121-130 of 446) with videos related to

Sort By:
Pageof 45
European Urology Focus|May 7, 2021
Predicting Complications After Robotic Partial Nephrectomy: Back to SimplicityZine-Eddine Khene, Clément Mazouin, Alessandro Larcher, et al.
European Urology|August 9, 2011
The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core systematic schemeVincenzo Scattoni, Marco Raber, Umberto Capitanio, et al.
European Urology Oncology|May 18, 2019
Is Robot-assisted Surgery Contraindicated in the Case of Partial Nephrectomy for Complex Tumours or Relevant Comorbidities? A Comparative Analysis of Morbidity, Renal Function, and Oncologic OutcomesAlessandro Larcher, Umberto Capitanio, Geert De Naeyer, et al.
European Urology Open Science|January 5, 2023
Local Treatment of Recurrent Renal Cell Carcinoma May Have a Significant Survival Effect Across All Risk-of-recurrence GroupsLorenzo Marconi, Teele Kuusk, Umberto Capitanio, et al.
European Urology|September 2, 2009
Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsyVincenzo Scattoni, Marco Raber, Firas Abdollah, et al.
Current Problems in Cancer|June 9, 2022
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidenceUmberto Capitanio, Giuseppe Fallara, Daniele Raggi, et al.
World Journal of Urology|July 27, 2018
Predictive and prognostic effect of inflammatory lymphadenopathies in renal cell carcinomaFabio Muttin, Angela Pecoraro, Alessandro Larcher, et al.
The Prostate|August 1, 2025
Assessing Predictors of Failure After Bladder Neck Incision in Patients Who Developed Bladder Neck Stenosis Following Transurethral Surgery for Benign Prostatic EnlargementLeonardo Quarta, Marco Bandini, Christian Corsini, et al.
Current Problems in Cancer|June 16, 2021
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors?Giuseppe Fallara, Marco Bandini, Alessandro Larcher, et al.
BJU International|October 1, 2010
How can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implicationsUmberto Capitanio, Federico Pellucchi, Andrea Gallina, et al.
Pageof 45